Advertisement

Topics

Hexal Australia Company Profile

05:16 EST 15th December 2017 | BioPortfolio

Hexal Australia was formed as a joint venture with Hexal AG, Germany in 1995 under the leadership of Clemens von Oswald. After an intensive preparation period prior to launching the company, two products were released onto the market in August 1997.Currently Hexal Australia has a product base of 45 active substances and 118 product lines. Hexal Australia plans to substantially expand the range further.
Hexal Australia is now recognised as a major force within the Australian generic medicines (lower cost brands) market segment.

Location

Level 4, Suite 1-6, 100 Harris Street
Pyrmont
New South Wales
NSW 2009
Australia

Contact

Phone: 61 2 9566 1500
Fax: 61 2 9566 1458


News Articles [285 Associated News Articles listed on BioPortfolio]

Human medicines European public assessment report (EPAR): Filgrastim Hexal, filgrastim, Revision: 12, Authorised

Human medicines European public assessment report (EPAR): Temozolomide Hexal, temozolomide, Revision: 13, Authorised

Human medicines European public assessment report (EPAR): Epoetin Alfa Hexal, epoetin alfa, Revision: 18, Authorised

Luggage screening intensified after Australia airplane plot

CANBERRA, Australia (AP) — Security remained heightened in airports around Australia with more intense screening of luggage after law enforcement officials thwarted what a police chief described on ...

Kelly Services Acquires Scientific Staffing Company In Australia

Kelly Services Inc. (Troy, MI), a global provider of staffing services, has signed an agreement to acquire LabStaff, Pty, Ltd. (Sydney, Australia) and its related companies in Australia...

UN accuses Australia of breaching refugee deal

The UN accused Australia Monday of backtracking on a deal to relax its strong stance on asylum-seekers and resettle some refugees now held in overseas detention on home soil. The UN High Commissioner...

Reforms will tighten regulation of CAR T-cell therapies in Australia

Australia’s medicines regulator, the Therapeutic Goods Administration, has announced it will reform…

Australia’s TGA progresses Provisional Approval pathway for medicines

Australia’s Therapeutic Good Administration (TGA) has released draft guidance documentation for the…

PubMed Articles [451 Associated PubMed Articles listed on BioPortfolio]

Dietitians Association of Australia 34th National Conference, "Cultivating Fresh Evidence", Hobart, Tasmania, Australia, 18-20 May 2017.

A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012.

Rates of new HIV-1 diagnoses are increasing in Australia, with evidence of an increasing proportion of non-B HIV-1 subtypes reflecting a growing impact of migration and travel. The present study aims ...

Laparoscopic pancreaticoduodenectomy in Brisbane, Australia: an initial experience.

The role of minimally invasive approach for pancreaticoduodenectomy has not yet been well defined in Australia. We present our early experience with laparoscopic pancreaticoduodenectomy (LPD) from Bri...

Identifying factors that lead to the persistence of imported gonorrhoeae strains: a modelling study.

The importation of Neisseria gonorrhoeae (NG) strains from overseas is believed to be the main source of antimicrobial resistance in Australia. With recent sporadic cases of ceftriaxone-resistant gono...

Immunisation for refugees in Australia: a policy review and analysis across all States and Territories.

Although people of refugee background are likely to be under-immunised before and after resettlement, no study to date has evaluated refugee specific immunisation policies in Australia. We developed a...

Clinical Trials [128 Associated Clinical Trials listed on BioPortfolio]

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

This is a randomized, controlled, double-blind, multicenter multinational safety study involving about 300 predialysis patients aged 18 years or above suffering from anemia. Symptomatic a...

Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors

Data collection on the safety and efficacy of Zarzio® / Filgrastim HEXAL® in adult healthy unrelated stem cell donors undergoing peripheral blood progenitor cell mobilization.

Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial

Despite all prevention efforts, many people in Australia continue to be infected with HIV. The Seventh National HIV Strategy 2014-2017 in Australia aims to work towards the elimination of ...

Patient Retention in HIV Medical Care in a Primary Care Practice in Australia

The purpose of this study is to determine linkage and retention in care in patients with HIV infection and reasons for loss to follow up Care in a High HIV-caseload Inner City Primary Care...

Control and Eradication Within Australia of Hepatitis C From People Living With HIV

The purpose of this study is to evaluate the feasibility of rapid scale-up of new hepatitis C (HCV) treatments, known as interferon-free Direct Acting Antiviral (DAA) drugs, and impact on ...

Companies [436 Associated Companies listed on BioPortfolio]

Hexal Australia

Hexal Australia was formed as a joint venture with Hexal AG, Germany in 1995 under the leadership of Clemens von Oswald. After an intensive preparation period prior to launching the company, two produ...

Food Science Australia

Food Science Australia is Australia's largest and most diversified food research organisation and a joint venture of CSIRO and the Victorian Government. We are committed to turning scientific researc...

Australia-New Zealand Biotech Alliance

A Memorandum of Understanding between the Governments of New South Wales, Queensland, South Australia, Tasmania, Victoria, Western Australia, the Australian Capital Territory, the Northern Territory a...

Novotech (Australia) Pty Ltd

Novotech is the largest independent CRO in Australia. With operations in the US, Novotech is uniquely positioned to offer clinical research services on the ground in both the US and Australia/New Zea...

George Weber & Associates

George Weber & Associates is a well established, successful healthcare marketing practice based in Sydney, Australia. Its client base includes companies from the U.S. Australia, Hong Kong and Singapor...

More Information about "Hexal Australia" on BioPortfolio

We have published hundreds of Hexal Australia news stories on BioPortfolio along with dozens of Hexal Australia Clinical Trials and PubMed Articles about Hexal Australia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hexal Australia Companies in our database. You can also find out about relevant Hexal Australia Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record